Literature DB >> 21212777

Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors.

Kazim H Narsinh1, Fangjun Jia, Robert C Robbins, Mark A Kay, Michael T Longaker, Joseph C Wu.   

Abstract

Human induced pluripotent stem cells (hiPSCs) derived from patient samples have tremendous potential for innovative approaches to disease pathology investigation and regenerative medicine therapies. However, most hiPSC derivation techniques use integrating viruses, which may leave residual transgene sequences as part of the host genome, thereby unpredictably altering cell phenotype in downstream applications. In this study, we describe a protocol for hiPSC derivation by transfection of a simple, nonviral minicircle DNA construct into human adipose stromal cells (hASCs). Minicircle DNA vectors are free of bacterial DNA and thus capable of high expression in mammalian cells. Their repeated transfection into hASCs, abundant somatic cell sources that are amenable to efficient reprogramming, results in transgene-free hiPSCs. This protocol requires only readily available molecular biology reagents and expertise, and produces hiPSC colonies from an adipose tissue sample in ∼4 weeks.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21212777      PMCID: PMC3657506          DOI: 10.1038/nprot.2010.173

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  30 in total

1.  Analysis of fluorescent protein expressing cells by flow cytometry.

Authors:  Steven C Pruitt; Lawrence M Mielnicki; Carleton C Stewart
Journal:  Methods Mol Biol       Date:  2004

2.  Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.

Authors:  Zhi-Ying Chen; Cheng-Yi He; Mark A Kay
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

Review 3.  Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells.

Authors:  Bo Feng; Jia-Hui Ng; Jian-Chien Dominic Heng; Huck-Hui Ng
Journal:  Cell Stem Cell       Date:  2009-04-03       Impact factor: 24.633

Review 4.  Flow cytometric analysis and FACS sorting of cells based on GFP accumulation.

Authors:  D W Galbraith; M T Anderson; L A Herzenberg
Journal:  Methods Cell Biol       Date:  1999       Impact factor: 1.441

5.  Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC.

Authors:  Tetsuhiro Aoki; Hiroe Ohnishi; Yasuaki Oda; Mika Tadokoro; Mari Sasao; Hiroyuki Kato; Koji Hattori; Hajime Ohgushi
Journal:  Tissue Eng Part A       Date:  2010-07       Impact factor: 3.845

6.  Growth and differentiation of human adipose stromal cells in culture.

Authors:  B Strutt; W Khalil; D Killinger
Journal:  Methods Mol Med       Date:  1996

7.  Variation in the safety of induced pluripotent stem cell lines.

Authors:  Kyoko Miura; Yohei Okada; Takashi Aoi; Aki Okada; Kazutoshi Takahashi; Keisuke Okita; Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Mari Ohnuki; Daisuke Ogawa; Eiji Ikeda; Hideyuki Okano; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2009-07-09       Impact factor: 54.908

8.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

9.  Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

Authors:  Gabsang Lee; Eirini P Papapetrou; Hyesoo Kim; Stuart M Chambers; Mark J Tomishima; Christopher A Fasano; Yosif M Ganat; Jayanthi Menon; Fumiko Shimizu; Agnes Viale; Viviane Tabar; Michel Sadelain; Lorenz Studer
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  77 in total

1.  Craniofacial reconstruction with induced pluripotent stem cells.

Authors:  Derrick C Wan; Victor W Wong; Michael T Longaker
Journal:  J Craniofac Surg       Date:  2012-05       Impact factor: 1.046

2.  Murine melanoma cells incomplete reprogramming using non-viral vector.

Authors:  D A D Câmara; A S Porcacchia; A S Costa; R A Azevedo; I Kerkis
Journal:  Cell Prolif       Date:  2017-06-15       Impact factor: 6.831

3.  Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.

Authors:  Eirini P Papapetrou; Michel Sadelain
Journal:  Nat Protoc       Date:  2011-08-04       Impact factor: 13.491

4.  Generation of skeletal myogenic progenitors from human pluripotent stem cells using non-viral delivery of minicircle DNA.

Authors:  Jaemin Kim; Vanessa K P Oliveira; Ami Yamamoto; Rita C R Perlingeiro
Journal:  Stem Cell Res       Date:  2017-07-12       Impact factor: 2.020

Review 5.  Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.

Authors:  Xinwen Zhang; Di Hu; Yutong Shang; Xin Qi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-18       Impact factor: 5.187

6.  The evolving biology of cell reprogramming.

Authors:  Ian Wilmut; Gareth Sullivan; Ian Chambers
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

7.  The prospect of induced pluripotent stem cells for diabetes mellitus treatment.

Authors:  Andreas Soejitno; Pande Kadek Aditya Prayudi
Journal:  Ther Adv Endocrinol Metab       Date:  2011-10       Impact factor: 3.565

Review 8.  CD117(+) amniotic fluid stem cells: state of the art and future perspectives.

Authors:  Mara Cananzi; Paolo De Coppi
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

Review 9.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

10.  Reprogramming human fibroblasts to pluripotency using modified mRNA.

Authors:  Pankaj K Mandal; Derrick J Rossi
Journal:  Nat Protoc       Date:  2013-02-21       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.